Strategies to improve adherence to insulin FDC in patients with T2D: are you up to speed [presentation] Presentation uri icon
  • In this Corporate Symposium, the learner will demonstrate greater competence in overcoming barriers related to effective insulin use in T2D management. New insulin + GLP-1 receptor agonist combination therapies have the potential to revolutionize diabetes management. When available, clinicians—especially diabetes educators—will be required to have a deep understanding of the clinical safety and efficacy these new products so they can educate patients appropriately.

  • participant
  • Kruger, D. F.   Presenter  
  • Powers, M. A.   Presenter  
  • Triplitt, C.   Presenter  
  • Research
  • Diabetes
  • Drugs and Drug Therapy
  • Health Education
  • Patient Compliance
  • Safety